Hani Susianti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hani Susianti has a total of 175 co-authors. Here are the top co-authors by number of shared publications:
Kusworini Handono
Clinical Pathology Department, Faculty of Medicine Brawijaya University/Dr. Saiful Anwar General Hospital, Malang, Indonesia
7 shared publicationsHandono Kalim
Division of Reumatology & Immunology, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145
5 shared publications- Kusworini Handono
Department of Clinical Pathology, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, Indonesia
4 shared publications Agustin Iskandar
Department of Clinical Pathology, Faculty of Medicine, Universitas Brawijaya - Saiful Anwar Hospital, Malang, Indonesia
3 shared publications- Agustin Iskandar
Biomedical Central Laboratory, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
3 shared publications - Jonny Karunia Fajar
Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, 65145, Indonesia
3 shared publications
Latest Publications
- Open Access
- 15 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0339255
Multicenter evaluation of BACT-Info. and an infection algorithm using Urine Flow Cytometry among clinically diagnosed UTI patients in Indonesia.
Urinary tract infections (UTIs) are the most common infections in both outpatient and inpatient settings, contributing significantly to morbidity, reduced quality of life, and antimicrobial overuse. Although urine culture remains the diagnostic gold standard, it poses practical limitations in clinical workflows. Rapid diagnostic methods such as urine flow cytometry (UF) offer potential for timely, reliable UTI detection. We conducted a multicenter diagnostic study to evaluate the performance of BACT-Info. and UTI-Info. flags on the UF-5000/4000 system in detecting UTIs, using presumptive Gram staining and urine culture (≥10⁵ CFU/mL) as references. A total of 763 patients with suspected UTI were enrolled, and 721 patients-with uropathogenic bacteria and complete data-were included in the final analysis (384 with culture-confirmed UTI and 337 without UTI). The diagnostic value of nitrituria was highly specific, while leukocyte esterase was sensitive. For BACT-count and WBC-count of UF-5000/4000, the AUCs were 0.85 and 0.69, respectively. Using cutoffs of WBC > 82.05/µL or bacteria >975.4/µL, the UTI-Info flag demonstrated 89% sensitivity, 54% specificity, 69% positive predictive value, and 82% negative predictive value. Positive and negative likelihood ratios were 1.93 and 0.20, respectively. The agreement between the BACT-Info. flag and Gram typing showed Kappa values of 0.716 for Gram-negative and 0.216 for Gram-positive bacteria when compared to culture, and 0.721 and 0.401, respectively, when compared to presumptive Gram staining. The UF-5000/4000 UTI-Info. and BACT-Info. flags show promise as a rapid UTI screening tool. The combination of these flags with urinalysis parameters, nitrite testing and leukocyte has potential to be developed into a diagnostic algorithm for early and sensitive UTI prediction. Such an approach may reduce unnecessary urine cultures and support timely, appropriate empiric antibiotic therapy. Establishing optimal cutoffs tailored to specific clinical settings is essential to enhance diagnostic accuracy and improve clinical utility.
- 15 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0339255
Open AccessMulticenter evaluation of BACT-Info. and an infection algorithm using Urine Flow Cytometry among clinically diagnosed UTI patients in Indonesia.
Urinary tract infections (UTIs) are the most common infections in both outpatient and inpatient settings, contributing significantly to morbidity, reduced quality of life, and antimicrobial overuse. Although urine culture remains the diagnostic gold standard, it poses practical limitations in clinical workflows. Rapid diagnostic methods such as urine flow cytometry (UF) offer potential for timely, reliable UTI detection. We conducted a multicenter diagnostic study to evaluate the performance of BACT-Info. and UTI-Info. flags on the UF-5000/4000 system in detecting UTIs, using presumptive Gram staining and urine culture (≥10⁵ CFU/mL) as references. A total of 763 patients with suspected UTI were enrolled, and 721 patients-with uropathogenic bacteria and complete data-were included in the final analysis (384 with culture-confirmed UTI and 337 without UTI). The diagnostic value of nitrituria was highly specific, while leukocyte esterase was sensitive. For BACT-count and WBC-count of UF-5000/4000, the AUCs were 0.85 and 0.69, respectively. Using cutoffs of WBC > 82.05/µL or bacteria >975.4/µL, the UTI-Info flag demonstrated 89% sensitivity, 54% specificity, 69% positive predictive value, and 82% negative predictive value. Positive and negative likelihood ratios were 1.93 and 0.20, respectively. The agreement between the BACT-Info. flag and Gram typing showed Kappa values of 0.716 for Gram-negative and 0.216 for Gram-positive bacteria when compared to culture, and 0.721 and 0.401, respectively, when compared to presumptive Gram staining. The UF-5000/4000 UTI-Info. and BACT-Info. flags show promise as a rapid UTI screening tool. The combination of these flags with urinalysis parameters, nitrite testing and leukocyte has potential to be developed into a diagnostic algorithm for early and sensitive UTI prediction. Such an approach may reduce unnecessary urine cultures and support timely, appropriate empiric antibiotic therapy. Establishing optimal cutoffs tailored to specific clinical settings is essential to enhance diagnostic accuracy and improve clinical utility.
- Open Access
Multicenter Evaluation of BACT-Info. and an Infection Algorithm Using Urine Flow Cytometry among Clinically Diagnosed UTI Patients in Indonesia
Urinary tract infections (UTIs) are the most common infections in both outpatient and inpatient settings, contributing significantly to morbidity, reduced quality of life, and antimicrobial overuse. Although urine culture remains the diagnostic gold standard, it poses practical limitations in clinical workflows. Rapid diagnostic methods such as urine flow cytometry (UF) offer potential for timely, reliable UTI detection. We conducted a multicenter diagnostic study to evaluate the performance of BACT-Info. and UTI-Info. flags on the UF-5000/4000 system in detecting UTIs, using presumptive Gram staining and urine culture (>10⁵ CFU/mL) as references. A total of 763 patients with suspected UTI were enrolled, and 721 patients—with uropathogenic bacteria and complete data—were included in the final analysis (384 with culture-confirmed UTI and 337 without UTI). The diagnostic value of nitrituria was highly specific, while leukocyte esterase was sensitive. For BACT-count and WBC-count of UF-5000/4000, the AUCs were 0.85 and 0.69, respectively. Using cutoffs of WBC >82.05/µL or bacteria >975.4/µL, the UTI-Info flag demonstrated 89% sensitivity, 54% specificity, 69% positive predictive value, and 82% negative predictive value. Positive and negative likelihood ratios were 1.93 and 0.20, respectively. The agreement between the BACT-Info. flag and Gram typing showed Kappa values of 0.716 for Gram-negative and 0.216 for Gram-positive bacteria when compared to culture, and 0.721 and 0.401, respectively, when compared to presumptive Gram staining. The UF-5000/4000 UTI-Info. and BACT-Info. flags show promise as a rapid UTI screening tool. The combination of these flags with urinalysis parameters, nitrite testing and leukocyte has potential to be developed into a diagnostic algorithm for early and sensitive UTI prediction. Such an approach may reduce unnecessary urine cultures and support timely, appropriate empiric antibiotic therapy. Establishing optimal cutoffs tailored to specific clinical settings is essential to enhance diagnostic accuracy and improve clinical utility.
Open AccessMulticenter Evaluation of BACT-Info. and an Infection Algorithm Using Urine Flow Cytometry among Clinically Diagnosed UTI Patients in Indonesia
Urinary tract infections (UTIs) are the most common infections in both outpatient and inpatient settings, contributing significantly to morbidity, reduced quality of life, and antimicrobial overuse. Although urine culture remains the diagnostic gold standard, it poses practical limitations in clinical workflows. Rapid diagnostic methods such as urine flow cytometry (UF) offer potential for timely, reliable UTI detection. We conducted a multicenter diagnostic study to evaluate the performance of BACT-Info. and UTI-Info. flags on the UF-5000/4000 system in detecting UTIs, using presumptive Gram staining and urine culture (>10⁵ CFU/mL) as references. A total of 763 patients with suspected UTI were enrolled, and 721 patients—with uropathogenic bacteria and complete data—were included in the final analysis (384 with culture-confirmed UTI and 337 without UTI). The diagnostic value of nitrituria was highly specific, while leukocyte esterase was sensitive. For BACT-count and WBC-count of UF-5000/4000, the AUCs were 0.85 and 0.69, respectively. Using cutoffs of WBC >82.05/µL or bacteria >975.4/µL, the UTI-Info flag demonstrated 89% sensitivity, 54% specificity, 69% positive predictive value, and 82% negative predictive value. Positive and negative likelihood ratios were 1.93 and 0.20, respectively. The agreement between the BACT-Info. flag and Gram typing showed Kappa values of 0.716 for Gram-negative and 0.216 for Gram-positive bacteria when compared to culture, and 0.721 and 0.401, respectively, when compared to presumptive Gram staining. The UF-5000/4000 UTI-Info. and BACT-Info. flags show promise as a rapid UTI screening tool. The combination of these flags with urinalysis parameters, nitrite testing and leukocyte has potential to be developed into a diagnostic algorithm for early and sensitive UTI prediction. Such an approach may reduce unnecessary urine cultures and support timely, appropriate empiric antibiotic therapy. Establishing optimal cutoffs tailored to specific clinical settings is essential to enhance diagnostic accuracy and improve clinical utility.
- Open Access
- 1 July 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (4) , 1168-1177
Exhaled volatile organic compound profiles as potential biomarkers for lung cancer: A study of ethanol, formaldehyde, and toluene
Context: The early diagnosis and detection of lung cancer are crucial for reducing mortality and morbidity. Recently, the study of biomarkers for diagnosis and early detection has expanded significantly. Several volatile organic compounds (VOCs) found in exhaled breath may serve as valuable indicators for the early detection of lung cancer, which is influenced by pathological factors associated with cancer development. Aims: To create a profile of VOCs in lung cancer patients and healthy controls and to examine the differences in VOC levels among lung cancer patients based on histological type, stage, and therapy. Methods: A cross-sectional study was conducted involving lung cancer patients receiving treatment at Saiful Anwar General Hospital. A total of 40 lung cancer patients and 40 healthy controls who met the inclusion criteria were recruited through total sampling. VOC levels were measured using the Ubreath sensor array method. Statistical analysis of VOC variables was performed utilizing the Kruskal-Wallis and Mann-Whitney tests. Results: An analysis of three VOCs—ethanol, formaldehyde, and toluene—showed significantly higher levels in lung cancer patients compared to healthy controls (p<0.05 for all three compounds). However, no significant differences in the levels of ethanol, formaldehyde, and toluene were observed based on histological type, stage, or therapy among lung cancer patients. Conclusions: Elevated concentrations of ethanol, formaldehyde, and toluene in exhaled breath suggest their potential as biomarkers for lung cancer detection.
- 1 July 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (4) , 1168-1177
Open AccessExhaled volatile organic compound profiles as potential biomarkers for lung cancer: A study of ethanol, formaldehyde, and toluene
Context: The early diagnosis and detection of lung cancer are crucial for reducing mortality and morbidity. Recently, the study of biomarkers for diagnosis and early detection has expanded significantly. Several volatile organic compounds (VOCs) found in exhaled breath may serve as valuable indicators for the early detection of lung cancer, which is influenced by pathological factors associated with cancer development. Aims: To create a profile of VOCs in lung cancer patients and healthy controls and to examine the differences in VOC levels among lung cancer patients based on histological type, stage, and therapy. Methods: A cross-sectional study was conducted involving lung cancer patients receiving treatment at Saiful Anwar General Hospital. A total of 40 lung cancer patients and 40 healthy controls who met the inclusion criteria were recruited through total sampling. VOC levels were measured using the Ubreath sensor array method. Statistical analysis of VOC variables was performed utilizing the Kruskal-Wallis and Mann-Whitney tests. Results: An analysis of three VOCs—ethanol, formaldehyde, and toluene—showed significantly higher levels in lung cancer patients compared to healthy controls (p<0.05 for all three compounds). However, no significant differences in the levels of ethanol, formaldehyde, and toluene were observed based on histological type, stage, or therapy among lung cancer patients. Conclusions: Elevated concentrations of ethanol, formaldehyde, and toluene in exhaled breath suggest their potential as biomarkers for lung cancer detection.
- Open Access
- 30 June 2025
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 16 (3) , 211-222
The role of vitamin D and the VDR gene polymorphism in sepsis risk and mortality: a systematic review and meta-analysis
Objectives: Vitamin D regulates immune function, cell proliferation, and differentiation. Its deficiency is linked to sepsis, although the causal relationship remains unclear. Studies suggest a strong correlation between FokI polymorphism and sepsis in the context of vitamin D deficiency. This study examined the association between vitamin D levels, the VDR FokI polymorphism, and sepsis risk through a systematic review and meta-analysis.Methods: Relevant articles from 2014–2024 were identified from various databases, including PubMed, Scopus, and Cochrane. A meta-analysis was conducted to assess the difference in vitamin D levels between the sepsis and control groups, as well as the relationship between VDR FokI genotypes (TT, CT, CC) and sepsis risk.Results: Vitamin D levels in sepsis patients were consistently lower than in the control group, with a mean difference of –4.17 ng/mL (95% confidence interval, –7.87 to –0.47; p=0.03). However, the relationship between VDR FokI genotype and sepsis risk was not statistically significant (p>0.05), although several individual studies showed a positive correlation. High heterogeneity was found in the analysis of vitamin D levels (I2=100%) and FokI genotypes (I2=91%), which affected the interpretation of the results.Conclusion: Vitamin D deficiency is a potential risk factor for sepsis, while the relationship between the VDR FokI polymorphism and sepsis risk requires further investigation. These findings highlight the importance of early detection of vitamin D deficiency as a preventive strategy in at-risk populations, although additional studies with more standardized designs are needed to definitively confirm this relationship.
- 30 June 2025
- Published by Korea Disease Control and Prevention Agency in Osong Public Health and Research Perspectives
- Vol. 16 (3) , 211-222
Open AccessThe role of vitamin D and the VDR gene polymorphism in sepsis risk and mortality: a systematic review and meta-analysis
Objectives: Vitamin D regulates immune function, cell proliferation, and differentiation. Its deficiency is linked to sepsis, although the causal relationship remains unclear. Studies suggest a strong correlation between FokI polymorphism and sepsis in the context of vitamin D deficiency. This study examined the association between vitamin D levels, the VDR FokI polymorphism, and sepsis risk through a systematic review and meta-analysis.Methods: Relevant articles from 2014–2024 were identified from various databases, including PubMed, Scopus, and Cochrane. A meta-analysis was conducted to assess the difference in vitamin D levels between the sepsis and control groups, as well as the relationship between VDR FokI genotypes (TT, CT, CC) and sepsis risk.Results: Vitamin D levels in sepsis patients were consistently lower than in the control group, with a mean difference of –4.17 ng/mL (95% confidence interval, –7.87 to –0.47; p=0.03). However, the relationship between VDR FokI genotype and sepsis risk was not statistically significant (p>0.05), although several individual studies showed a positive correlation. High heterogeneity was found in the analysis of vitamin D levels (I2=100%) and FokI genotypes (I2=91%), which affected the interpretation of the results.Conclusion: Vitamin D deficiency is a potential risk factor for sepsis, while the relationship between the VDR FokI polymorphism and sepsis risk requires further investigation. These findings highlight the importance of early detection of vitamin D deficiency as a preventive strategy in at-risk populations, although additional studies with more standardized designs are needed to definitively confirm this relationship.
- Open Access
- 1 June 2025
- Published by Taylor & Francis in Journal of Blood Medicine
- Vol. ume 16, 269-277
Transplantation of Human Peripheral Stem and Progenitor Cells to Humanized Mouse Model for Systemic Lupus Erythematosus
Introduction: Systemic Lupus Erythematosus (SLE) is an autoimmune disease characterized by damaged and dysregulated immune system due to breakdown in the selection process during clonal growth of immune cells. Studies have shown that patients with systemic lupus erythematosus (SLE) display altered gene expression patterns and increased double-stranded DNA breaks within their hematopoietic stem and progenitor cells (HSPC). However, the current animal models for SLE found in the existing literature predominantly emphasize the use of peripheral blood mononuclear cells (PBMC) over HSPC for the creation of humanized mouse models. Nevertheless, these prior models were constrained by the limited efficiency of human cell engraftment and limited PBMC ability to replicate the capacity of HSPC to generate human SLE cells that can engraft host mice, thus making the transplant protocol inadequate. Patients and Methods: Transplantation was initiated by extracting HSPC from stable SLE patients by leukapheresis. The collected cells were assessed for purity before storage at − 80 °C. Humanized mice were conditioned with cyclophosphamide and total-body irradiation before receiving the HSPC transplant. After transplantation, the mice were administered human granulocyte-colony stimulating factor and sacrificed to evaluate autoantibodies and HSPC in their bone marrow and blood samples. Statistical analysis was performed using Student’s t-test and one-way ANOVA. Results: Upon human stem cells engravement into mice, we found a noteworthy presence of HSPC, as evidenced by the positive expression of hCD45, hCD34, and/or hCD44, and the production of human antinuclear antibodies. The results indicated that the transplanted mice generated reactive autoantibodies against human cells, similar to that observed in the human donor patient. These findings shed light on the survival and behavior of transplanted human stem cells in a mouse model. Conclusion: In this study, we successfully induced immunodeficiency in mice for xenotransplantation with human peripheral stem cells.
- 1 June 2025
- Published by Taylor & Francis in Journal of Blood Medicine
- Vol. ume 16, 269-277
Open AccessTransplantation of Human Peripheral Stem and Progenitor Cells to Humanized Mouse Model for Systemic Lupus Erythematosus
Introduction: Systemic Lupus Erythematosus (SLE) is an autoimmune disease characterized by damaged and dysregulated immune system due to breakdown in the selection process during clonal growth of immune cells. Studies have shown that patients with systemic lupus erythematosus (SLE) display altered gene expression patterns and increased double-stranded DNA breaks within their hematopoietic stem and progenitor cells (HSPC). However, the current animal models for SLE found in the existing literature predominantly emphasize the use of peripheral blood mononuclear cells (PBMC) over HSPC for the creation of humanized mouse models. Nevertheless, these prior models were constrained by the limited efficiency of human cell engraftment and limited PBMC ability to replicate the capacity of HSPC to generate human SLE cells that can engraft host mice, thus making the transplant protocol inadequate. Patients and Methods: Transplantation was initiated by extracting HSPC from stable SLE patients by leukapheresis. The collected cells were assessed for purity before storage at − 80 °C. Humanized mice were conditioned with cyclophosphamide and total-body irradiation before receiving the HSPC transplant. After transplantation, the mice were administered human granulocyte-colony stimulating factor and sacrificed to evaluate autoantibodies and HSPC in their bone marrow and blood samples. Statistical analysis was performed using Student’s t-test and one-way ANOVA. Results: Upon human stem cells engravement into mice, we found a noteworthy presence of HSPC, as evidenced by the positive expression of hCD45, hCD34, and/or hCD44, and the production of human antinuclear antibodies. The results indicated that the transplanted mice generated reactive autoantibodies against human cells, similar to that observed in the human donor patient. These findings shed light on the survival and behavior of transplanted human stem cells in a mouse model. Conclusion: In this study, we successfully induced immunodeficiency in mice for xenotransplantation with human peripheral stem cells.
- Open Access
- 1 May 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (3) , 744-756
Colchicine as inhibitor of caspase-1 and GSTO-1 to regulate inflammation-induced pyroptosis in ischemic heart disease: A computational investigation
Context: Inflammation-induced pyroptosis amplification contributes to the deterioration of ischemic heart diseases (IHD). Triggered by inflammasome activation, it provokes inflammatory reactions involving proteins such as glutathione transferase omega-1 (GSTO-1), NLRP-3 inflammasome, and caspase-1 (CASP-1), which might be prevented by colchicine. However, the mechanism remains to be explored. Aims: To explore colchicine's potential to inhibit CASP-1, GSTO-1, and NLRP-3 to alleviate pyroptosis by mean computational methods. Methods: Structures of colchicine, CASP-1, GSTO1-1, and NLRP3 were obtained from databases, followed by molecular docking and dynamics simulations to evaluate colchicine's inhibitory potential. NSC697923 and KT53 were used as reference compounds to validate the docking and molecular dynamics analyses. Results: Molecular docking showed that colchicine binds to CASP-1 and GSTO-1 with lower binding energy than their native ligands, indicating strong inhibitory potential. Molecular dynamics simulations further confirmed that colchicine forms stable and robust interactions with CASP-1 and GSTO-1, supporting its effectiveness as an inhibitor. In contrast, colchicine’s interaction with NLRP-3 was less stable, suggesting a lower inhibitory potential. Comparative analysis with NSC697923 and KT53, potent inhibitors of CASP-1 and GSTO-1, respectively, reinforced colchicine’s stable conformation and sufficient hydrogen bonds despite its slightly higher binding affinity, underscoring its sustained interaction with CASP-1 and GSTO-1. Conclusions: Colchicine showed a promising inhibitory potential agent against CASP-1 and GSTO-1, highlighting its potential for regulating inflammation in IHD. The stable binding of colchicine to CASP-1 and GSTO-1 indicated a potential inhibitory mechanism against inflammation-induced pyroptosis in IHD.
- 1 May 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (3) , 744-756
Open AccessColchicine as inhibitor of caspase-1 and GSTO-1 to regulate inflammation-induced pyroptosis in ischemic heart disease: A computational investigation
Context: Inflammation-induced pyroptosis amplification contributes to the deterioration of ischemic heart diseases (IHD). Triggered by inflammasome activation, it provokes inflammatory reactions involving proteins such as glutathione transferase omega-1 (GSTO-1), NLRP-3 inflammasome, and caspase-1 (CASP-1), which might be prevented by colchicine. However, the mechanism remains to be explored. Aims: To explore colchicine's potential to inhibit CASP-1, GSTO-1, and NLRP-3 to alleviate pyroptosis by mean computational methods. Methods: Structures of colchicine, CASP-1, GSTO1-1, and NLRP3 were obtained from databases, followed by molecular docking and dynamics simulations to evaluate colchicine's inhibitory potential. NSC697923 and KT53 were used as reference compounds to validate the docking and molecular dynamics analyses. Results: Molecular docking showed that colchicine binds to CASP-1 and GSTO-1 with lower binding energy than their native ligands, indicating strong inhibitory potential. Molecular dynamics simulations further confirmed that colchicine forms stable and robust interactions with CASP-1 and GSTO-1, supporting its effectiveness as an inhibitor. In contrast, colchicine’s interaction with NLRP-3 was less stable, suggesting a lower inhibitory potential. Comparative analysis with NSC697923 and KT53, potent inhibitors of CASP-1 and GSTO-1, respectively, reinforced colchicine’s stable conformation and sufficient hydrogen bonds despite its slightly higher binding affinity, underscoring its sustained interaction with CASP-1 and GSTO-1. Conclusions: Colchicine showed a promising inhibitory potential agent against CASP-1 and GSTO-1, highlighting its potential for regulating inflammation in IHD. The stable binding of colchicine to CASP-1 and GSTO-1 indicated a potential inhibitory mechanism against inflammation-induced pyroptosis in IHD.
- Open Access
- 14 January 2025
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (3) , 1848-1860
The ADESTE Trial: A Phase 2 Study of Enibarcimab, a Monoclonal Antibody Targeting Adrenomedullin, in Acute Heart Failure
Aims: This study aimed to conduct a phase 2 proof-of-concept and safety study to evaluate the effect of ENIBARCIMAB (EN), a non-neutralizing humanized monoclonal antibody targeting the N-terminus of adrenomedullin (ADM), administered immediately after stabilization with standard of care (SoC) treatment, in patients hospitalized for acute heart failure (AHF). Methods and results: This prospective, open-label, controlled, interventional, multicenter, dose-escalation study was conducted at two cardiology sites in Indonesia. Patients were divided into two interventional groups sequentially receiving 0.5 mg/kg (SoC + EN 0.5 mg/kg, n = 10; first cohort) and 2 mg/kg (SoC + EN 2 mg/kg, n = 10; second cohort) of EN via 1-h intravenous (IV) infusion within 48 h after admission for AHF. The control group (n = 10) was treated with SoC therapy for AHF therapy. All patients were monitored continuously within 24 h post-infusion and subsequent daily until discharge. Treatment-related serious adverse events (SAEs) were recorded during hospitalization and up to 90 days after discharge. Both EN dosages were well-tolerated, and no significant safety issues were identified during hospitalization and up to 90 days of follow up. SAEs occurred in 10% of patients in each EN group but were deemed not related to treatment. No significant differences in the occurrence of SAEs were found between the groups. Five deaths occurred: three (30%) in the control group as compared with two deaths (20%) in the SoC + EN 2 mg/kg group. EN led to a significant increase in plasma bio-ADM levels within 24 h post-infusion, with the SoC + 2 mg/kg group showing the highest increase. Within 1 h from IV EN infusion, SoC + EN 2 mg/kg compared with 0.5 mg/kg, resulted in a significant percentage reduction in systolic, diastolic blood pressure, and mean arterial pressure. However, it did not result in severe hypotension and the need for drug discontinuation. Conclusions: In this pilot safety study of patients hospitalized for AHF, IV infusion of EN 0.5 and 2 mg/kg increased circulating plasma bio-ADM levels and was well-tolerated without treatment-related SAEs occurring during hospitalization and up to 90 days after discharge.
- 14 January 2025
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (3) , 1848-1860
Open AccessThe ADESTE Trial: A Phase 2 Study of Enibarcimab, a Monoclonal Antibody Targeting Adrenomedullin, in Acute Heart Failure
Aims: This study aimed to conduct a phase 2 proof-of-concept and safety study to evaluate the effect of ENIBARCIMAB (EN), a non-neutralizing humanized monoclonal antibody targeting the N-terminus of adrenomedullin (ADM), administered immediately after stabilization with standard of care (SoC) treatment, in patients hospitalized for acute heart failure (AHF). Methods and results: This prospective, open-label, controlled, interventional, multicenter, dose-escalation study was conducted at two cardiology sites in Indonesia. Patients were divided into two interventional groups sequentially receiving 0.5 mg/kg (SoC + EN 0.5 mg/kg, n = 10; first cohort) and 2 mg/kg (SoC + EN 2 mg/kg, n = 10; second cohort) of EN via 1-h intravenous (IV) infusion within 48 h after admission for AHF. The control group (n = 10) was treated with SoC therapy for AHF therapy. All patients were monitored continuously within 24 h post-infusion and subsequent daily until discharge. Treatment-related serious adverse events (SAEs) were recorded during hospitalization and up to 90 days after discharge. Both EN dosages were well-tolerated, and no significant safety issues were identified during hospitalization and up to 90 days of follow up. SAEs occurred in 10% of patients in each EN group but were deemed not related to treatment. No significant differences in the occurrence of SAEs were found between the groups. Five deaths occurred: three (30%) in the control group as compared with two deaths (20%) in the SoC + EN 2 mg/kg group. EN led to a significant increase in plasma bio-ADM levels within 24 h post-infusion, with the SoC + 2 mg/kg group showing the highest increase. Within 1 h from IV EN infusion, SoC + EN 2 mg/kg compared with 0.5 mg/kg, resulted in a significant percentage reduction in systolic, diastolic blood pressure, and mean arterial pressure. However, it did not result in severe hypotension and the need for drug discontinuation. Conclusions: In this pilot safety study of patients hospitalized for AHF, IV infusion of EN 0.5 and 2 mg/kg increased circulating plasma bio-ADM levels and was well-tolerated without treatment-related SAEs occurring during hospitalization and up to 90 days after discharge.
- 1 December 2024
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 20 (5) , 586-594
Randomised Clinical Trial Study: The Combination of Vitamin D and Curcumin Piperine Attenuates Disease Activity and Pro-inflammatory Cytokines Levels Insystemic Lupus Erythematosus Patients
Background:: Curcumin-piperine might synergise with vitamin D to induce clinical remission in patients with systemic lupus erythematosus (SLE). Objective:: To observe the improvement of patients with SLE clinically and the levels of inflammatory cytokines after receiving supplements of curcumin-piperine and cholecalciferol (Vitamin D3). Methods:: Forty-five female SLE patients were included in a three-month double-blind, randomized controlled trial. Participants were classified into: Group I (400 IU cholecalciferol + placebo three times daily, n = 15), Group II (600 mg curcumin + 15,800 m piperine once daily and three times daily placebo, n = 15), and Group III (cholecalciferol 400 IU three times and 600 mg curcumin + 15,800 mg piperine once a day, n = 15). Mexican SLE disease activity score (Mex- SLEDAI), fatigue severity scale (FSS), TGF-β, and IL-6 levels were measured from all patients before and after the treatments. Results:: Mex-SLEDAI, FSS, and IL-6 were reduced significantly, while TGF-β serum levels were increased in all groups after the treatments (p <0.05). Changes in Mex-SLEDAI score (p = 0.003 and p = 0.008), FSS (p = 0.001 and p <0.001), and TGF-β (p = 0.003 and p = 0.004) serum levels were significantly higher in group III compared to the group I or group II. On the other hand, changes in Mex-SLEDAI, FSS, IL-6, and TGF-β serum levels were similar between groups I and II. Conclusion:: Although vitamin D or curcumin-piperine alone could improve the clinical outcome and cytokines levels in SLE, curcumin-piperine combined with vitamin D had the best outcome in improving the disease activity and cytokines levels among patients with SLE. (ClinicalTrials.gov number, NCT05430087).
- 1 December 2024
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 20 (5) , 586-594
Randomised Clinical Trial Study: The Combination of Vitamin D and Curcumin Piperine Attenuates Disease Activity and Pro-inflammatory Cytokines Levels Insystemic Lupus Erythematosus Patients
Background:: Curcumin-piperine might synergise with vitamin D to induce clinical remission in patients with systemic lupus erythematosus (SLE). Objective:: To observe the improvement of patients with SLE clinically and the levels of inflammatory cytokines after receiving supplements of curcumin-piperine and cholecalciferol (Vitamin D3). Methods:: Forty-five female SLE patients were included in a three-month double-blind, randomized controlled trial. Participants were classified into: Group I (400 IU cholecalciferol + placebo three times daily, n = 15), Group II (600 mg curcumin + 15,800 m piperine once daily and three times daily placebo, n = 15), and Group III (cholecalciferol 400 IU three times and 600 mg curcumin + 15,800 mg piperine once a day, n = 15). Mexican SLE disease activity score (Mex- SLEDAI), fatigue severity scale (FSS), TGF-β, and IL-6 levels were measured from all patients before and after the treatments. Results:: Mex-SLEDAI, FSS, and IL-6 were reduced significantly, while TGF-β serum levels were increased in all groups after the treatments (p <0.05). Changes in Mex-SLEDAI score (p = 0.003 and p = 0.008), FSS (p = 0.001 and p <0.001), and TGF-β (p = 0.003 and p = 0.004) serum levels were significantly higher in group III compared to the group I or group II. On the other hand, changes in Mex-SLEDAI, FSS, IL-6, and TGF-β serum levels were similar between groups I and II. Conclusion:: Although vitamin D or curcumin-piperine alone could improve the clinical outcome and cytokines levels in SLE, curcumin-piperine combined with vitamin D had the best outcome in improving the disease activity and cytokines levels among patients with SLE. (ClinicalTrials.gov number, NCT05430087).
- Open Access
- 1 September 2024
- Published by International Society of Communication and Development Between Universities (ISCDBU) in Journal of Medicinal and Chemical Sciences
- Vol. 7 (9) , 1183-1192
Diagnostic Performance of IL-1β and C-Reactive Protein in Childhood Tuberculosis
Interleukin (IL)-1β, a proinflammatory cytokine produced by phagocytes infected with Mycobacterium tuberculosis, is known for its stability in storage, which ensures consistent measurement in clinical settings. This stability, along with its unaffected levels by age, sex, or lung disease severity, makes IL-1β a promising biomarker in tuberculosis (TB). This study aims to evaluate the diagnostic performance of IL-1β and C-reactive protein (CRP) in childhood TB. cross-sectional study was conducted on 77 children with suspected TB at Saiful Anwar Hospital. The inclusion criteria were based on the 2016 technical guidelines for TB. IL-1β levels were measured using Elisa, while CRP was assessed via immunoturbidimetry. A significant difference in mean IL-1β levels was observed between the TB and non-TB groups (p = 0.028). However, IL-1β showed a weak correlation with the TB group (r = 0.251, p = 0.027). The area under the curve (AUC) for IL-1β was 0.671 (p = 0.028) with 52.5% sensitivity, 83.3% specificity, 91.1% positive predictive value (PPV), 34.8% negative predictive value (NPV), and 59.7% accuracy at a cut-off of 6.1 pg/mL. CRP levels showed no significant correlation or difference between the groups. The combination of IL-1β and CRP yielded an AUC of 0.669 (p = 0.031), with 41.5% sensitivity, 75% specificity, 84.4% PPV, 28.1% NPV, and 49.3% accuracy. Although IL-1β shows moderate diagnostic performance and CRP alone or combined with IL-1β has limited utility in diagnosing childhood TB, IL-1β still holds potential as a biomarker. Its high positive predictive value (PPV) indicates strong reliability in confirming TB, making it a valuable tool in a broader diagnostic or monitoring of childhood TB.
- 1 September 2024
- Published by International Society of Communication and Development Between Universities (ISCDBU) in Journal of Medicinal and Chemical Sciences
- Vol. 7 (9) , 1183-1192
Open AccessDiagnostic Performance of IL-1β and C-Reactive Protein in Childhood Tuberculosis
Interleukin (IL)-1β, a proinflammatory cytokine produced by phagocytes infected with Mycobacterium tuberculosis, is known for its stability in storage, which ensures consistent measurement in clinical settings. This stability, along with its unaffected levels by age, sex, or lung disease severity, makes IL-1β a promising biomarker in tuberculosis (TB). This study aims to evaluate the diagnostic performance of IL-1β and C-reactive protein (CRP) in childhood TB. cross-sectional study was conducted on 77 children with suspected TB at Saiful Anwar Hospital. The inclusion criteria were based on the 2016 technical guidelines for TB. IL-1β levels were measured using Elisa, while CRP was assessed via immunoturbidimetry. A significant difference in mean IL-1β levels was observed between the TB and non-TB groups (p = 0.028). However, IL-1β showed a weak correlation with the TB group (r = 0.251, p = 0.027). The area under the curve (AUC) for IL-1β was 0.671 (p = 0.028) with 52.5% sensitivity, 83.3% specificity, 91.1% positive predictive value (PPV), 34.8% negative predictive value (NPV), and 59.7% accuracy at a cut-off of 6.1 pg/mL. CRP levels showed no significant correlation or difference between the groups. The combination of IL-1β and CRP yielded an AUC of 0.669 (p = 0.031), with 41.5% sensitivity, 75% specificity, 84.4% PPV, 28.1% NPV, and 49.3% accuracy. Although IL-1β shows moderate diagnostic performance and CRP alone or combined with IL-1β has limited utility in diagnosing childhood TB, IL-1β still holds potential as a biomarker. Its high positive predictive value (PPV) indicates strong reliability in confirming TB, making it a valuable tool in a broader diagnostic or monitoring of childhood TB.
- Open Access
- 1 March 2024
- Published by Taylor & Francis in International Journal of Nephrology and Renovascular Disease
- Vol. ume 17, 105-112
Acute Kidney Injury Prediction Model Using Cystatin-C, Beta-2 Microglobulin, and Neutrophil Gelatinase-Associated Lipocalin Biomarker in Sepsis Patients
Introduction: AKI is a frequent complication in sepsis patients and is estimated to occur in almost half of patients with severe sepsis. However, there is currently no effective therapy for AKI in sepsis. Therefore, the therapeutic approach is focused on prevention. Based on this, there is an opportunity to examine a panel of biomarker models for predicting AKI. Material and Methods: This prospective cohort study analysed the differences in Cystatin C, Beta-2 Microglobulin, and NGAL levels in sepsis patients with AKI and sepsis patients without AKI. The biomarker modelling of AKI prediction was done using machine learning, namely Orange Data Mining. In this study, 130 samples were analysed by machine learning. The parameters used to obtain the biomarker panel were 23 laboratory examination parameters. Results: This study used SVM and the Naïve Bayes model of machine learning. The SVM model’s sensitivity, specificity, NPV, and PPV were 50%, 94.4%, 71.4%, and 87.5%, respectively. For the Naïve Bayes model, the sensitivity, specificity, NPV, and PPV were 83.3%, 77.8%, 87.5%, and 71.4%, respectively. Discussion: This study’s SVM machine learning model has higher AUC and specificity but lower sensitivity. The Naïve Bayes model had better sensitivity; it can be used to predict AKI in sepsis patients. Conclusion: The Naïve Bayes machine learning model in this study is useful for predicting AKI in sepsis patients.
- 1 March 2024
- Published by Taylor & Francis in International Journal of Nephrology and Renovascular Disease
- Vol. ume 17, 105-112
Open AccessAcute Kidney Injury Prediction Model Using Cystatin-C, Beta-2 Microglobulin, and Neutrophil Gelatinase-Associated Lipocalin Biomarker in Sepsis Patients
Introduction: AKI is a frequent complication in sepsis patients and is estimated to occur in almost half of patients with severe sepsis. However, there is currently no effective therapy for AKI in sepsis. Therefore, the therapeutic approach is focused on prevention. Based on this, there is an opportunity to examine a panel of biomarker models for predicting AKI. Material and Methods: This prospective cohort study analysed the differences in Cystatin C, Beta-2 Microglobulin, and NGAL levels in sepsis patients with AKI and sepsis patients without AKI. The biomarker modelling of AKI prediction was done using machine learning, namely Orange Data Mining. In this study, 130 samples were analysed by machine learning. The parameters used to obtain the biomarker panel were 23 laboratory examination parameters. Results: This study used SVM and the Naïve Bayes model of machine learning. The SVM model’s sensitivity, specificity, NPV, and PPV were 50%, 94.4%, 71.4%, and 87.5%, respectively. For the Naïve Bayes model, the sensitivity, specificity, NPV, and PPV were 83.3%, 77.8%, 87.5%, and 71.4%, respectively. Discussion: This study’s SVM machine learning model has higher AUC and specificity but lower sensitivity. The Naïve Bayes model had better sensitivity; it can be used to predict AKI in sepsis patients. Conclusion: The Naïve Bayes machine learning model in this study is useful for predicting AKI in sepsis patients.